Word count: 3,954ABSTRACT Poor diets and obesity are associated with inflammation and insulin resistance (IR), but the physiological regulation of insulin sensitivity (IS) is not completely understood. We report that miR-467, induced by elevated blood glucose levels, decreases inflammation and IR in a diet-induced IR model. In Western diet-fed mice, miR-467 antagonist injections increased IR compared to mice injected with a control oligonucleotide. In mice injected with the antagonist, we detected elevated blood glucose (143 vs 121.7 mg/dL); higher plasma insulin levels (98 vs 63 ng/mL); lower insulin sensitivity; increased adipocyte size; and increased recruitment of macrophages into adipose tissue and pancreas (by 47% in adipose tissue; 44% in pancreas), without increases in weight or lipoproteins and cholesterol levels.Lack of miR-467 antagonist effects in Thbs1 -/mice (deficient in thrombospondin-1, TSP-1, a target of miR-467 that we have experimentally confirmed elsewhere) in response to the miR-467 antagonist suggested that TSP-1 mediates some effects of miR-467 in preventing IR. Not all effects by the miR-467 antagonist were abolished in Thbs1 -/mice and their macrophages, suggesting that miR-467 employs multiple targets in regulating inflammation and IR.Our results demonstrate that miR-467 provides a physiological feedback to prevent inflammation and IR in response to dietary signals.
RESEARCH DESIGN AND METHODS
Experimental animalsAnimal procedures were approved by the Institutional Animal Care and Use Committee.Mice were fed a chow or Western diet (TD.88137, 40-45% kcal from fat, 34% sucrose by weight, Envigo) starting at 4 weeks of age and injected weekly with a miR-467 antagonist (2.5 mg/kg body weight), intraperitoneally, starting at 5 weeks of age until the end of the experiment.
miR-467 mimic and the miR-467 antagonistThe miR-467 mimic and the control oligonucleotide were purchased from Dharmacon.Cholesterol conjugated miR-467 was modified by tagging of the fluorophore DY547 and a cholesterol moiety. The custom LNA-modified miR-467 antagonist (TacaTGcaGGcacTTa) and a control oligonucleotide (TTTaGaccgaGcgTGt) were from Qiagen.
Glucose and insulin tolerance tests (GTT and ITT)GTT and ITT were administered after overnight fasting. Glucose (2 g/kg body weight) or insulin (50 mg/kg) (Sigma) were injected intraperitoneally. Blood glucose levels were measured 0 -180 min after the injection using an AlphaTRAK glucometer.
Induction of diabetes in miceMice were given IP streptozotocin (STZ, Sigma) injections (50 mg/kg) for 5 consecutive days. Mice with blood glucose >250 mg/dL were selected for experiments.
Blood cell counts, lipoprotein profile, and cytokines in bloodBlood was collected by cardiac puncture, and circulating blood cell counts were analyzed using an ADVIA 120 Hematology System (Siemens). Plasma insulin was measured using an Insulin Mouse ELISA kit (Thermo).A custom U-plex Assay Platform (MSD) was used to assess plasma levels of IL-1β, IL-2, IL-4, IL-6, IL-10, KC, MCP-1, MIP-1β, TNF-α, and VEG...